Free Trial

Synthetic Biologics (SYN) News Today

Synthetic Biologics logo
What’s Next in Synthetic Biology?
Q3 2024 Exelixis Inc Earnings Call
Revisiting Humacyte
Old-Line Rheum Drugs Lose Luster in JIA
AI Simulations Help Drug Trials
Get Synthetic Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYN and its competitors with MarketBeat's FREE daily newsletter.

SYN Media Mentions By Week

SYN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SYN
News Sentiment

0.13

1.03

Average
Medical
News Sentiment

SYN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SYN Articles
This Week

3

1

SYN Articles
Average Week

Get Synthetic Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSEAMERICAN:SYN) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners